1. Mohd.Gayoor Khan. “The novel drug delivery system”, World journal of pharmacy and pharmaceutical sciences, Vol-6, Issue 7,477-487 ISSN 2278-4357.
2. https:/www.sciencedirect.com/science/article/pii/B9780081025482000019.
3. Vrunal V. More, Ritu M. Gilhotra, Manoj M. Nitalikar, Prajakta K. Khule , “Niosomal drug delivery” Asian journal of pharmaceutics, Oct-Dec 2018 (suppl) 12(4)|S1159].
4. Mohamed Shafik E1-Ridy, Soad Aly Yehia, Amira Mohamed Mohsen, Sally A E1-Awdan and AsmaaBadawyDarwish. “Formulation of niosomla gel foe enhanced transdermal Lornoxicam delivery: In-vitro and In-vivo evaluation”, Current drug delivery,2018,15,122-133
5. Varsha B. Patil, Sandip A. Tadvi, Sunil P. Pawar."Formulation of Niosomal Gel of Aceclofenac and it's In-vitro Characterization " Asian Journal of Drugs,2017, 5/(2) 78-87.
6. AartiHardia, DarshanJamindar, Amisha Mahajan, AashishHardia“ Formuation and In vitro and skin permeability evaluation of Dexamethasone loaded Niosomal gel” ,Asian journal of pharmaceutical research and development, Vol5(2)March-April.2017:1-09.
7. Moghassemi S, Hadjizadeh A (July 2014). "Nano-niosomes as nanoscale drug delivery systems: an illustrated review". Journal of Controlled Release. 185: 22–36. doi:10.1016/j.jconrel.2014.04.015. PMID 24747765.
8. Buckton G., Harwood, Interfacial phenomena in Drug Delivery and Targeting Academic Publishers, Switzerland. 1995; p.154-155.
9. Khan A, Sharma PK, Visht S, Malviya R. Niosomes as colloidal drug delivery system: a review. Journal of Chronotherapy and Drug Delivery. 2011;2:15–21.
10. Gayatri Devi S, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for nasal administration. Int J Pharm Sci 2000;62:479-81.
11. Baillie A.J., Coombs G.H. and Dolan T.F. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate J.Pharm.Pharmacol. 1986; 38: 502-505.
12. Raja Naresh R.A., Chandrashekhar G., Pillai G.K. and Udupa N. Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween -85 in Arthitic rats. Ind.J.Pharmacol. 1994; 26:46-48.
13. Maver L.D. Bally M.B. Hope. M.J. Cullis P.R. Biochem Biophys. Acta (1985), 816:294-302.
14. Chauhan S. and Luorence M.J. The preparation of polyoxyethylene containing non-ionic surfactant. vesicles. J. Pharm. Pharmacol. 1989; 41: 6p.
15. Blazek-Walsh A.I. and Rhodes D.G. Pharm. Res. SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. 2001; 18: 656-661.
16. Baillie AJ, Coombs GH, Dolan TF, Laurie J. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol. 1986;38:502–5.
17. Khandare JN, Madhavi G, Tamhankar BM. Niosomes novel drug delivery system. East Pharmacist. 1994;37:61–4.
18. Jayaraman SC, Ramachandran C, Weiner N. Topical delivery of erythromycin from various formulations: An in vivo hairless mouse study. J Pharm Sci. 1996;85:1082–4.
19. Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328:130–41.
20. Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicines by a noisome system. Int J Pharm. 2002;244:73–80.
21. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33–70.
22. S. Moghassemi and A. Hadjizadeh, “Nano-niosomes as nanoscale drug delivery systems: an illustrated review,” Journal of Controlled Release, vol. 185, no. 1, pp. 22–36, 2014.
23. Moghassemi S, Hadjizadeh A (July 2014). "Nano-niosomes as nanoscale drug delivery systems: an illustrated review". Journal of Controlled Release. 185: 22–36.
24. Puras G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Martínez Navarrete G, Avilés-Trigueros M, Fernández E, Pedraz JL (January 2014). "A novel cationic niosome formulation for gene delivery to the retina". Journal of Controlled Release. 174: 27–36.
25. Aggarwal G, Goel A, Dhawan S, Shama A (2010). "Carriers/vesicles based approaches for penetration enhancement in transdermal drug delivery (1 - 5).